Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
Year: 2015
Type: article
Study design: Clinical Trial
Source: Annals of the Rheumatic Diseases
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2291801226
